NCT06716554 is a NA clinical trial of Shatavari extract in Menopause, sponsored by SF Research Institute, Inc..

Who is sponsoring NCT06716554?

NCT06716554 is sponsored by SF Research Institute, Inc..

What drugs are being tested in NCT06716554?

Interventions in NCT06716554: Shatavari extract, Shatavari + Ashwagandha extract, Placebo.

What condition does NCT06716554 study?

NCT06716554 studies Menopause, Hot Flashes, Mood.

Is NCT06716554 still recruiting?

NCT06716554 is currently recruiting now. Last updated 4 December 2024.

Last reviewed 2024-12-04 · How we verify

NCT06716554

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Efficacy and Safety of Shatavari for Treatment of Menopausal Symptoms in Women: A Randomized, Double-blind, Three-arm, Parallel, Placebo-controlled Study

Recruiting now NA Last updated 4 December 2024

What this trial tests

NA trial testing Shatavari extract in Menopause in 51 participants. Currently enrolling.

Timeline

26 October 2024

Primary endpoint
26 December 2024

20 January 2025

Quick facts

Lead sponsor	SF Research Institute, Inc.
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	51
Start date	26 October 2024
Primary completion	26 December 2024
Estimated completion	20 January 2025
Sites	1 location across United States

Drugs / interventions tested

Shatavari extract
Shatavari + Ashwagandha extract
Placebo

Conditions studied

Menopause — all drugs for Menopause →
Hot Flashes — all drugs for Hot Flashes →
Mood — all drugs for Mood →

Sponsor

SF Research Institute, Inc.

Who can join

Adults 45 to 55, female only, with Menopause or Hot Flashes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a Multi-center, Multi-national, Prospective, Randomized, Double-Blind, Placebo- Controlled three arm study to evaluate the efficacy and safety of Shatavari for the treatment of Menopausal symptoms in Women. Participants will be randomized to either one of the three treatment arms.Participants will then be asked to either take one capsule containing Shatavari or Shatavari + Ashwagandha or Placebo orally once daily in the morning after breakfast with a glass of water for 8 weeks. All the subjects will be asked to continue their routine diet and physical activities during the whole study period. The primary objective is to compare the efficacy of shatavari for treatment of menopausal symptoms in women. The secondary objective is to compare the safety of shatavari for treatment of menopausal symptoms in women.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Efficacy and safety of Shatavari root extract (<i>Asparagus racemosus</i>) for menopausal symptoms: a randomized, double-blind, three-arm, placebo-controlled study.
Ademola J, Ajgaonkar A, Debnath T, Debnath K, et al · · 2025 · PMID 41394012 · DOI 10.3389/frph.2025.1654503

Verify or expand the search:

Other recruiting trials for Menopause

Currently open trials in the same condition.

NCT07472881 — Multi-Acupoint Laser Therapy for Body Shape and Composition in Obese Menopausal Women · NA · recruiting
NCT07135232 — The Effects of Resistance Training and a Plant-Based Supplement on Perimenopausal Symptoms and Muscle Health. · NA · recruiting
NCT06975111 — Focusing on the Menopausal Transition to Improve Mid-Life Women's Health · Phase 2, PHASE3 · recruiting
NCT07393672 — Effects of Hemp-Derived Cannabinoids on Menopause Symptoms · Phase 2 · recruiting
NCT07412093 — The Effect of Progressive Relaxation Exercises and Planned Education on Menopausal Symptoms, Perceived Stress, and Anxie · NA · active not recruiting

Other SF Research Institute, Inc. trials

Trials by the same sponsor.

NCT07441070 — Effect of Ashwagandha Root Extract on Stress, Anxiety, and Sleep Quality in Adults Experiencing Minority Stress · NA · enrolling by invitation
NCT07441096 — Efficacy and Safety of Shatavari Root Extract for Premenstrual Syndrome in Women · NA · not yet recruiting
NCT07441083 — Efficacy and Safety of Shatavari Root Extract in Women's Sexual Wellness · NA · not yet recruiting
NCT07441109 — Shatavari Root Extract for Perimenopausal Symptoms · NA · not yet recruiting
NCT07421596 — An 8-Week Study Evaluating Gut and Digestive Health After Use of a Dietary Supplement System · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06716554 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by SF Research Institute, Inc.
Last refreshed: 4 December 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06716554.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing